CD163 and neoplasm: In head and neck oncology, Ryu et al[25] reported that perineural invasion, PD-L1 positivity, and a higher ratio of CD163-positive tumor infiltrating macrophages to CD8-positive tumor infiltrating lymphocytes were independent factors for poor progression-free survival in young patients.